CardioDx Receives $7,369,475 Series D Financing Round

  • Feed Type
  • Date
    2/23/2016
  • Company Name
    CardioDx
  • Mailing Address
    600 Saginaw Drive Redwood City, CA 94063 USA
  • Company Description
    Founded in 2004, CardioDx is a cardiovascular genomic diagnostics company. CardioDx develops clinically validated genomic tests to aid in assessing and tailoring care of individuals with cardiovascular disease, including coronary artery disease (CAD), cardiac arrhythmias, and heart failure.
  • Website
    http://www.cardiodx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $7,369,475
  • Transaction Round
    Series D
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 15 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed